Rudick, R A <br/><br/>
Estimating long-term effects of disease-modifying drug therapy in multiple sclerosis patients.  [electronic resource] 

 -  Multiple sclerosis (Houndmills, Basingstoke, England)  Dec 2005 
 - 626-34 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1352-4585 
<br/><br/><label>Standard No.: </label>10.1191/1352458505ms1203oa  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--therapeutic use<br/>Disability Evaluation<br/>Disease Progression<br/>Follow-Up Studies<br/>Humans<br/>Interferon beta-1a<br/>Interferon-beta--therapeutic use<br/>Models, Statistical<br/>Multiple Sclerosis, Relapsing-Remitting--drug therapy<br/>Randomized Controlled Trials as Topic--methods